Annual report pursuant to section 13 and 15(d)

Note 10 - Commitments (Details)

v2.4.0.8
Note 10 - Commitments (Details) (USD $)
6 Months Ended 12 Months Ended 12 Months Ended
Sep. 30, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Co-Development Agreement [Member]
Paid [Member]
Dec. 31, 2009
Co-Development Agreement [Member]
Dec. 31, 2013
Shared Research Agreements [Member]
Dec. 31, 2012
Master Services and Software License Agreement [Member]
Previous Purchase [Member]
Dec. 31, 2012
Master Services and Software License Agreement [Member]
Additional Purchase [Member]
Dec. 31, 2012
Master Services and Software License Agreement [Member]
Dec. 31, 2013
Cardiac EP Business Participation Plan [Member]
Jun. 30, 2010
Cardiac EP Business Participation Plan [Member]
Note 10 - Commitments (Details) [Line Items]                      
Operating Leases, Rent Expense   $ 149,000 $ 145,000                
Contractual Obligation       1,373,889 2,476,000 274,000          
Stock Issued During Period, Shares, Purchase of Assets (in Shares)                 1,500,000    
License Costs             612,500 87,500      
Purchase Commitment, Remaining Minimum Amount Committed                 962,500    
Equity Method Investment, Ownership Percentage                   3.10% 6.60%
Bonus Payment to Each Participant in Key Personnel Incentive Program upon a Sale Transaction   1,000,000                  
Incentive Bonus Payment to One of the Participants as a Percentage of Net Proceeds from the Sale Transaction   1.40%                  
Net Proceeds from the Sale Transaction, Threshold Amount   50,000,000                  
Maximum Additional Incentive Bonus Payment to One Participant   700,000                  
Other Operating Income (Expense), Net $ 882,537   $ 882,537